Cancer Vaccines

Susan G. Komen for the Cure(R) Encourages President's Cancer Panel to Focus on More Collaboration and Partnerships to Accelerate Cancer Cures

Published in Vaccine Weekly, February 16th, 2011

2011 FEB 16 -- Susan G. Komen for the Cure®, the world's largest breast cancer organization, today encouraged the President's Cancer Panel to use its leadership position to expand partnerships that work toward greater collaboration, and asked for increased scientific focus on the critical unanswered questions in cancer.

Chandini Portteus, Komen for the Cure's vice president of research, evaluation and scientific programs, also testified that Komen is concentrating its research funding across many areas, with a focus on prevention and early detection; novel and personalized treatments for aggressive and metastatic cancers, and disparities in breast...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2011-02-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry